Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 2/20 | 0.34 |
| ▸ | ADH1A | P07327 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9979246 | 1.00 | ADH1C (0.34) | ADH1CADH1AADH1BSHBG | |
| SCHEMBL8852367 | 1.00 | ADH1C (0.34) | ADH1CADH1AADH1BSHBG | |
| SCHEMBL9979303 | 1.00 | ADH1C (0.34) | ADH1CADH1AADH1BSHBG | |
| SCHEMBL9978796 | 0.97 | — | — | |
| SCHEMBL9979108 | 0.91 | — | — | |
| SCHEMBL1221452 | 0.84 | — | — | |
| SCHEMBL22788473 | 0.78 | ADH1B (0.32) | ADH1CADH1AADH1B | |
| SCHEMBL8075544 | 0.76 | SHBG (0.32) | ADH1CADH1AADH1BSHBG | |
| SCHEMBL5919192 | 0.74 | SHBG (0.41) | ADH1CADH1AADH1BSHBG | |
| SCHEMBL7126650 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0243940-A2 | Phenyl- and cyclohexyl-isobutylpyrrolidine | BASF Aktiengesellschaft (DE) | 1987-11-04 | — | — | EP | claimed |
| WO-2021219495-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2021-11-04 | — | — | WO | disclosed |
| US-20210338626-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2021-11-04 | — | — | US | disclosed |
| EP-3215505-B1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | Bayer Pharma AG (DE) | 2019-07-24 | — | — | EP | disclosed |
| CN-110036068-A | Concentrate composition | 巴塞尔聚烯烃意大利有限公司 | 2019-07-19 | — | — | CN | disclosed |
| CN-109180843-A | The non-phthalic acid ester compound as electron donor for polyolefin catalyst | 美国台塑公司 | 2019-01-11 | — | — | CN | disclosed |
| US-10118930-B2 | Piperidinylpyrazolopyrimidinones and their use | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-11-06 | — | — | US | disclosed |
| CN-105339085-B | Non-phthalate compounds as electron donors for polyolefin catalysts | 美国台塑公司 | 2018-06-26 | — | — | CN | disclosed |
| EP-3277670-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER | Bristol-Myers Squibb Company (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3277672-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER | Bristol-Myers Squibb Company (US) | 2018-02-07 | — | — | EP | disclosed |
| US-20030092708-A1 | Anticholesterol agents; cardiovascular disorders; antilipemic agents | JAPAN TOBACCO, INC., A JAPAN CORPORATION | 2003-05-15 | — | — | US | disclosed |
| EP-1297101-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-0978531-B1 | Rubber composition | CONTINENTAL AG (DE) | 2003-02-19 | — | — | EP | disclosed |
| US-6426365-B1 | Anticholesterol agents; Cholesterol ester transfer protein (CETP); including dalcetrapib, S-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino) phenyl) 2-methylpropanethioate | JAPAN TOBACCO INC. (JP) | 2002-07-30 | — | — | US | disclosed |
| WO-2001085888-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6207757-B1 | VULCANIZABLE RUBBER CONTAINS, A RUBBER COMPONENT, A FILLER WITH NUCLEOPHILIC GROUP, AN ADDITIONAL FILLER, GEL PARTICLES COMPRISING RUBBER CONTAINING ELECTROPHILIC CENTERS, A NUCLEOPHIC GROUP CONTAINING SILANE COUPLER | CONTINENTAL AKTIENGESELLSCHAFT (DE) | 2001-03-27 | — | — | US | disclosed |
| EP-1020439-A1 | CETP ACTIVITY INHIBITORS | JAPAN TOBACCO INC. (JP) | 2000-07-19 | — | — | EP | disclosed |
| CN-1252053-A | Cetp activity inhibitors | JAPAN TOBACCO INC (JP) | 2000-05-03 | — | — | CN | disclosed |
| EP-0978531-A1 | Rubber composition | Continental Aktiengesellschaft (DE) | 2000-02-09 | — | — | EP | disclosed |
| US-4593090-A | Containing perhydrofuran or pyran ring structure | GOGO KIMURA (JP) | 1986-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338626-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | ACE, ACE2, REN | ADH1C 2220/4885ADH1A 2420/4885ADH1B 1573/4885 |
| US-20030092708-A1 | Anticholesterol agents; cardiovascular disorders; antilipemic agents | CETP, CES1, PON1 | ADH1C 778/4885ADH1A 707/4885ADH1B 788/4885 |
| US-10118930-B2 | Piperidinylpyrazolopyrimidinones and their use | HAMP, SERPINC1, PRSS8 | ADH1C 1025/4885ADH1A 673/4885ADH1B 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.